

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.08528370 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.06664063 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.05741679 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.83320253 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.50280512 |
| 6 | vocalization behavior (GO:0071625) | 4.47536857 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.35734385 |
| 8 | regulation of synapse structural plasticity (GO:0051823) | 4.34172761 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.30466612 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.30466612 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.30466612 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.30466612 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.30466612 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.30466612 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.30096944 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.19713643 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.15180618 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.13602219 |
| 19 | protein localization to endosome (GO:0036010) | 4.07811332 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.99204168 |
| 21 | glutamate secretion (GO:0014047) | 3.97455335 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.95002956 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 3.91523606 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.87897121 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.85665106 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.85272407 |
| 27 | prepulse inhibition (GO:0060134) | 3.81938398 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.81200316 |
| 29 | negative regulation of cell killing (GO:0031342) | 3.81132967 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.81132967 |
| 31 | protein localization to synapse (GO:0035418) | 3.77572486 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.71971373 |
| 33 | neurotransmitter secretion (GO:0007269) | 3.69236471 |
| 34 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.68327665 |
| 35 | exploration behavior (GO:0035640) | 3.67284828 |
| 36 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.65524041 |
| 37 | activation of protein kinase A activity (GO:0034199) | 3.62005679 |
| 38 | regulation of synaptic vesicle transport (GO:1902803) | 3.58430922 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 3.57051600 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.56972149 |
| 41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.55802476 |
| 42 | synaptic transmission, glutamatergic (GO:0035249) | 3.51391967 |
| 43 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.50747717 |
| 44 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.48568526 |
| 45 | neuron-neuron synaptic transmission (GO:0007270) | 3.43638907 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.40953344 |
| 47 | long-term memory (GO:0007616) | 3.39887779 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.39458099 |
| 49 | glutamate receptor signaling pathway (GO:0007215) | 3.36533182 |
| 50 | response to peptidoglycan (GO:0032494) | 3.36200873 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 3.34838876 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.34608255 |
| 53 | neuromuscular process controlling balance (GO:0050885) | 3.31822887 |
| 54 | regulation of ARF protein signal transduction (GO:0032012) | 3.31657212 |
| 55 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.30524532 |
| 56 | neuron cell-cell adhesion (GO:0007158) | 3.30171324 |
| 57 | cellular extravasation (GO:0045123) | 3.29274190 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 3.26466038 |
| 59 | positive regulation of membrane potential (GO:0045838) | 3.23396214 |
| 60 | regulation of postsynaptic membrane potential (GO:0060078) | 3.22529451 |
| 61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21713782 |
| 62 | behavioral response to cocaine (GO:0048148) | 3.15297120 |
| 63 | regulation of synaptic plasticity (GO:0048167) | 3.14585021 |
| 64 | auditory behavior (GO:0031223) | 3.14414600 |
| 65 | detection of other organism (GO:0098543) | 3.13602862 |
| 66 | hypotonic response (GO:0006971) | 3.12898557 |
| 67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.12043253 |
| 68 | dopamine receptor signaling pathway (GO:0007212) | 3.11802153 |
| 69 | proline transport (GO:0015824) | 3.11764388 |
| 70 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.11139690 |
| 71 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.09714585 |
| 72 | striatum development (GO:0021756) | 3.09228128 |
| 73 | response to laminar fluid shear stress (GO:0034616) | 3.08427796 |
| 74 | nuclear pore complex assembly (GO:0051292) | 3.08349649 |
| 75 | response to auditory stimulus (GO:0010996) | 3.04922216 |
| 76 | response to host (GO:0075136) | 3.04475188 |
| 77 | response to host defenses (GO:0052200) | 3.04475188 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.04475188 |
| 79 | positive regulation of synapse maturation (GO:0090129) | 3.03432728 |
| 80 | nerve growth factor signaling pathway (GO:0038180) | 3.02883511 |
| 81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.02351266 |
| 82 | detection of external biotic stimulus (GO:0098581) | 3.00936411 |
| 83 | neutrophil activation involved in immune response (GO:0002283) | 3.00023580 |
| 84 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.99725860 |
| 85 | leukocyte aggregation (GO:0070486) | 2.99239449 |
| 86 | neutrophil mediated immunity (GO:0002446) | 2.99171213 |
| 87 | long-term synaptic potentiation (GO:0060291) | 2.98616866 |
| 88 | regulation of dendritic spine development (GO:0060998) | 2.96869477 |
| 89 | sodium ion export (GO:0071436) | 2.96064276 |
| 90 | neuronal action potential propagation (GO:0019227) | 2.95132952 |
| 91 | vesicle transport along microtubule (GO:0047496) | 2.94723703 |
| 92 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93866245 |
| 93 | regulation of female receptivity (GO:0045924) | 2.93799879 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 2.93355425 |
| 95 | cAMP catabolic process (GO:0006198) | 2.91671397 |
| 96 | germinal center formation (GO:0002467) | 2.91393571 |
| 97 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91143870 |
| 98 | response to host immune response (GO:0052572) | 2.91143870 |
| 99 | iron ion import (GO:0097286) | 2.90667706 |
| 100 | positive regulation of neurotransmitter transport (GO:0051590) | 2.89414444 |
| 101 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88816095 |
| 102 | clathrin coat assembly (GO:0048268) | 2.87406200 |
| 103 | cellular potassium ion homeostasis (GO:0030007) | 2.86315800 |
| 104 | glycine transport (GO:0015816) | 2.85606808 |
| 105 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.84698863 |
| 106 | synaptic transmission, dopaminergic (GO:0001963) | 2.84227066 |
| 107 | cAMP biosynthetic process (GO:0006171) | 2.83099941 |
| 108 | response to interleukin-15 (GO:0070672) | 2.82862322 |
| 109 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.80591356 |
| 110 | membrane depolarization during action potential (GO:0086010) | 2.80521363 |
| 111 | transmission of nerve impulse (GO:0019226) | 2.80156619 |
| 112 | dendrite morphogenesis (GO:0048813) | 2.79965002 |
| 113 | neurotransmitter transport (GO:0006836) | 2.79111473 |
| 114 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78706771 |
| 115 | membrane depolarization (GO:0051899) | 2.77885193 |
| 116 | regulation of Rap GTPase activity (GO:0032317) | 2.77008761 |
| 117 | adenosine receptor signaling pathway (GO:0001973) | 2.76726124 |
| 118 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.76572485 |
| 119 | hepatocyte apoptotic process (GO:0097284) | 2.74865205 |
| 120 | cAMP metabolic process (GO:0046058) | 2.73460503 |
| 121 | regulation of neurotransmitter levels (GO:0001505) | 2.73031458 |
| 122 | regulation of glutamate secretion (GO:0014048) | 2.71917303 |
| 123 | response to amphetamine (GO:0001975) | 2.71038403 |
| 124 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.70273146 |
| 125 | detection of bacterium (GO:0016045) | 2.69888514 |
| 126 | regulation of leukocyte degranulation (GO:0043300) | 2.69246085 |
| 127 | regulation of gamma-delta T cell activation (GO:0046643) | 2.67443767 |
| 128 | neuronal ion channel clustering (GO:0045161) | 2.66694353 |
| 129 | behavioral defense response (GO:0002209) | 2.66090776 |
| 130 | behavioral fear response (GO:0001662) | 2.66090776 |
| 131 | granulocyte activation (GO:0036230) | 2.65650733 |
| 132 | regulation of neurotransmitter secretion (GO:0046928) | 2.65270159 |
| 133 | stress fiber assembly (GO:0043149) | 2.65204800 |
| 134 | mechanosensory behavior (GO:0007638) | 2.64896285 |
| 135 | regulation of necroptotic process (GO:0060544) | 2.64459586 |
| 136 | neuron recognition (GO:0008038) | 2.64209625 |
| 137 | visual learning (GO:0008542) | 2.62425691 |
| 138 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.62195034 |
| 139 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.61914195 |
| 140 | membrane hyperpolarization (GO:0060081) | 2.61348330 |
| 141 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.60708008 |
| 142 | learning (GO:0007612) | 2.60125170 |
| 143 | positive regulation of synaptic transmission (GO:0050806) | 2.59349753 |
| 144 | cyclic nucleotide catabolic process (GO:0009214) | 2.59223133 |
| 145 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.59036863 |
| 146 | response to muramyl dipeptide (GO:0032495) | 2.58533143 |
| 147 | neuromuscular process (GO:0050905) | 2.57829449 |
| 148 | synaptic vesicle endocytosis (GO:0048488) | 2.57391274 |
| 149 | negative regulation of dendrite development (GO:2000171) | 2.57129705 |
| 150 | neutrophil activation (GO:0042119) | 2.56824888 |
| 151 | embryonic process involved in female pregnancy (GO:0060136) | 2.56720308 |
| 152 | histone H3-K36 demethylation (GO:0070544) | 2.56641443 |
| 153 | L-amino acid import (GO:0043092) | 2.56257828 |
| 154 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.56228323 |
| 155 | detection of biotic stimulus (GO:0009595) | 2.52380580 |
| 156 | nuclear pore organization (GO:0006999) | 2.51845178 |
| 157 | regulation of defense response to virus by virus (GO:0050690) | 2.49983338 |
| 158 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.49720271 |
| 159 | skin morphogenesis (GO:0043589) | 2.48820520 |
| 160 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.47305156 |
| 161 | Golgi transport vesicle coating (GO:0048200) | 2.44913438 |
| 162 | COPI coating of Golgi vesicle (GO:0048205) | 2.44913438 |
| 163 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.44127443 |
| 164 | myeloid leukocyte mediated immunity (GO:0002444) | 2.43713283 |
| 165 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.43003369 |
| 166 | modulation by symbiont of host cellular process (GO:0044068) | 2.42055671 |
| 167 | cell adhesion mediated by integrin (GO:0033627) | 2.40075876 |
| 168 | peptidyl-threonine modification (GO:0018210) | 2.39853832 |
| 169 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.38650710 |
| 170 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37794901 |
| 171 | peptidyl-threonine phosphorylation (GO:0018107) | 2.36123639 |
| 172 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.35620360 |
| 173 | pentose-phosphate shunt (GO:0006098) | 2.34559126 |
| 174 | NIK/NF-kappaB signaling (GO:0038061) | 2.33804463 |
| 175 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.32998353 |
| 176 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.31235635 |
| 177 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.31144430 |
| 178 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.29123045 |
| 179 | regulation of mast cell degranulation (GO:0043304) | 2.28826783 |
| 180 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.27474752 |
| 181 | pore complex assembly (GO:0046931) | 2.27418376 |
| 182 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.26940747 |
| 183 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.26814635 |
| 184 | regulation of regulated secretory pathway (GO:1903305) | 2.26787345 |
| 185 | positive regulation of leukocyte degranulation (GO:0043302) | 2.26126469 |
| 186 | negative thymic T cell selection (GO:0045060) | 2.25825776 |
| 187 | B cell receptor signaling pathway (GO:0050853) | 2.25673930 |
| 188 | regulation of RNA export from nucleus (GO:0046831) | 2.25500654 |
| 189 | cellular response to type I interferon (GO:0071357) | 2.24253829 |
| 190 | type I interferon signaling pathway (GO:0060337) | 2.24253829 |
| 191 | regulation of macrophage cytokine production (GO:0010935) | 2.22589994 |
| 192 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.22227311 |
| 193 | cortical actin cytoskeleton organization (GO:0030866) | 2.21969129 |
| 194 | positive regulation of receptor recycling (GO:0001921) | 2.21775446 |
| 195 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.21304208 |
| 196 | dosage compensation (GO:0007549) | 2.20105717 |
| 197 | macrophage activation (GO:0042116) | 2.19814279 |
| 198 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.19395014 |
| 199 | response to type I interferon (GO:0034340) | 2.18914673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.62595468 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.08675087 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.54280422 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.39765973 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93359322 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.88335597 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.85974025 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83951355 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75865147 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69641520 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.61621349 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.56908634 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.51289646 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.43935669 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.42547529 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.37315808 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.35108124 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28989132 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.26137944 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21487510 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20827197 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20692670 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.19177695 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.18049032 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.17919462 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.14389605 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.13548366 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.06146963 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.05623820 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.05623820 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03925062 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.02170072 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.01635948 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99423632 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.95924632 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.95814492 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.93643268 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93616714 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.92959368 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91167273 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.90987441 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90695463 |
| 43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.88992535 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.87890784 |
| 45 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87478544 |
| 46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.86571820 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82736855 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80961010 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80433549 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.78283537 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77003439 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76282674 |
| 53 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75755703 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74595005 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71464255 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70564546 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67313651 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.67199291 |
| 59 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.66136664 |
| 60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65921869 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65580110 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64531728 |
| 63 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63374081 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62095690 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59485017 |
| 66 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.58942927 |
| 67 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.57934596 |
| 68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.57544895 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57360468 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56000331 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55653323 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54457391 |
| 73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54246532 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53489222 |
| 75 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.51458710 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48008021 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.47899327 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46222422 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45259471 |
| 80 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.43576787 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.43576787 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 1.42330584 |
| 83 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.41018474 |
| 84 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40945280 |
| 85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40416720 |
| 86 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39286362 |
| 87 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.37267514 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37218711 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36004021 |
| 90 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34453269 |
| 91 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34071163 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33731195 |
| 93 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33724341 |
| 94 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33256897 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32414949 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32243288 |
| 97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32112158 |
| 98 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30309026 |
| 99 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27518883 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27076629 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26892007 |
| 102 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.25924921 |
| 103 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24878386 |
| 104 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24496132 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24135952 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23500211 |
| 107 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22953652 |
| 108 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.22786117 |
| 109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22759940 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22691981 |
| 111 | AR_19668381_ChIP-Seq_PC3_Human | 1.22197290 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20654213 |
| 113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20476879 |
| 114 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18576831 |
| 115 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.18414216 |
| 116 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17824602 |
| 117 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17467189 |
| 118 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17324317 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16376554 |
| 120 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16018443 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15995955 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15799330 |
| 123 | MAF_26560356_Chip-Seq_TH2_Human | 1.15443197 |
| 124 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15206155 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15154257 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15043772 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14916291 |
| 128 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14816086 |
| 129 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13785273 |
| 130 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13471335 |
| 131 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12635139 |
| 132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12553864 |
| 133 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12393464 |
| 134 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12016075 |
| 135 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10857703 |
| 136 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10664856 |
| 137 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10498073 |
| 138 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09888755 |
| 139 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09788066 |
| 140 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07859078 |
| 141 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07836008 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07535566 |
| 143 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06110795 |
| 144 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05975710 |
| 145 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04402538 |
| 146 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04047452 |
| 147 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03692210 |
| 148 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03665889 |
| 149 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03520013 |
| 150 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02875198 |
| 151 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02831050 |
| 152 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02282960 |
| 153 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00923894 |
| 154 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99390840 |
| 155 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99330918 |
| 156 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98098679 |
| 157 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97221544 |
| 158 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97092851 |
| 159 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96797969 |
| 160 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96572685 |
| 161 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96509345 |
| 162 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96248172 |
| 163 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95767052 |
| 164 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.94661417 |
| 165 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94417718 |
| 166 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94412998 |
| 167 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.93582027 |
| 168 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93207706 |
| 169 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93200637 |
| 170 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93156547 |
| 171 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93121886 |
| 172 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92662371 |
| 173 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91149249 |
| 174 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90458618 |
| 175 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90205376 |
| 176 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89820466 |
| 177 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89688986 |
| 178 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88606906 |
| 179 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87560498 |
| 180 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87499294 |
| 181 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87328536 |
| 182 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87098547 |
| 183 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85975489 |
| 184 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85174523 |
| 185 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.84655304 |
| 186 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83468174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.55240070 |
| 2 | MP0002822_catalepsy | 5.49879964 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.93963947 |
| 4 | MP0003880_abnormal_central_pattern | 3.75299908 |
| 5 | MP0004270_analgesia | 3.58617730 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.44401929 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.30563809 |
| 8 | MP0009745_abnormal_behavioral_response | 3.25812875 |
| 9 | MP0005451_abnormal_body_composition | 2.95247505 |
| 10 | MP0002064_seizures | 2.94623179 |
| 11 | MP0008260_abnormal_autophagy | 2.90490443 |
| 12 | MP0003436_decreased_susceptibility_to | 2.73806674 |
| 13 | MP0009046_muscle_twitch | 2.71602601 |
| 14 | MP0003724_increased_susceptibility_to | 2.71367423 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.60171595 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.41033173 |
| 17 | MP0001486_abnormal_startle_reflex | 2.38066307 |
| 18 | MP0003329_amyloid_beta_deposits | 2.28026278 |
| 19 | MP0002272_abnormal_nervous_system | 2.26236722 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.19011337 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 2.18804633 |
| 22 | MP0003091_abnormal_cell_migration | 2.18318305 |
| 23 | MP0003566_abnormal_cell_adhesion | 2.16876402 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 2.12825574 |
| 25 | MP0001501_abnormal_sleep_pattern | 2.01168104 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.01070851 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.99905954 |
| 28 | MP0005076_abnormal_cell_differentiation | 1.96631633 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.95507288 |
| 30 | MP0002419_abnormal_innate_immunity | 1.89986640 |
| 31 | MP0004947_skin_inflammation | 1.89345841 |
| 32 | MP0008569_lethality_at_weaning | 1.87699253 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.85871776 |
| 34 | MP0004924_abnormal_behavior | 1.85871776 |
| 35 | MP0000858_altered_metastatic_potential | 1.82485682 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.81762659 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.79552255 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.79380234 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.78635691 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.77742122 |
| 41 | MP0002736_abnormal_nociception_after | 1.76006993 |
| 42 | MP0001440_abnormal_grooming_behavior | 1.75839070 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.74487218 |
| 44 | MP0000569_abnormal_digit_pigmentation | 1.73342503 |
| 45 | MP0000604_amyloidosis | 1.69457208 |
| 46 | MP0001970_abnormal_pain_threshold | 1.69060164 |
| 47 | MP0003828_pulmonary_edema | 1.67867399 |
| 48 | MP0004858_abnormal_nervous_system | 1.66212969 |
| 49 | MP0004264_abnormal_extraembryonic_tissu | 1.64292724 |
| 50 | MP0003633_abnormal_nervous_system | 1.63446935 |
| 51 | MP0004233_abnormal_muscle_weight | 1.63423308 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.61100445 |
| 53 | MP0005025_abnormal_response_to | 1.56787663 |
| 54 | MP0003075_altered_response_to | 1.56483227 |
| 55 | MP0002067_abnormal_sensory_capabilities | 1.54859178 |
| 56 | MP0004510_myositis | 1.54329572 |
| 57 | MP0001529_abnormal_vocalization | 1.53219527 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.53085263 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.50797689 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.49813284 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.48437686 |
| 62 | MP0003690_abnormal_glial_cell | 1.47078176 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.45393171 |
| 64 | MP0009278_abnormal_bone_marrow | 1.42583629 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.42442417 |
| 66 | MP0001800_abnormal_humoral_immune | 1.41487491 |
| 67 | MP0002405_respiratory_system_inflammati | 1.41465570 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.40239014 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.40159311 |
| 70 | MP0001984_abnormal_olfaction | 1.39711661 |
| 71 | MP0003631_nervous_system_phenotype | 1.39557217 |
| 72 | MP0001819_abnormal_immune_cell | 1.39475792 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.39449098 |
| 74 | MP0000685_abnormal_immune_system | 1.38749234 |
| 75 | MP0008874_decreased_physiological_sensi | 1.38702191 |
| 76 | MP0000778_abnormal_nervous_system | 1.37655530 |
| 77 | MP0001849_ear_inflammation | 1.37636952 |
| 78 | MP0006082_CNS_inflammation | 1.37181410 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 1.36538036 |
| 80 | MP0005646_abnormal_pituitary_gland | 1.35669241 |
| 81 | MP0009785_altered_susceptibility_to | 1.34037199 |
| 82 | MP0002557_abnormal_social/conspecific_i | 1.33880585 |
| 83 | MP0002723_abnormal_immune_serum | 1.33675545 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.32656940 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 1.32365046 |
| 86 | MP0005310_abnormal_salivary_gland | 1.30773281 |
| 87 | MP0003879_abnormal_hair_cell | 1.28602871 |
| 88 | MP0004130_abnormal_muscle_cell | 1.28432601 |
| 89 | MP0002398_abnormal_bone_marrow | 1.28221042 |
| 90 | MP0004885_abnormal_endolymph | 1.27971868 |
| 91 | MP0002009_preneoplasia | 1.27591881 |
| 92 | MP0002066_abnormal_motor_capabilities/c | 1.27245434 |
| 93 | MP0008057_abnormal_DNA_replication | 1.26669182 |
| 94 | MP0000920_abnormal_myelination | 1.25944968 |
| 95 | MP0000955_abnormal_spinal_cord | 1.25739291 |
| 96 | MP0003448_altered_tumor_morphology | 1.24804416 |
| 97 | MP0002006_tumorigenesis | 1.23906620 |
| 98 | MP0001790_abnormal_immune_system | 1.23480024 |
| 99 | MP0005387_immune_system_phenotype | 1.23480024 |
| 100 | MP0010155_abnormal_intestine_physiology | 1.20454085 |
| 101 | MP0000703_abnormal_thymus_morphology | 1.18740761 |
| 102 | MP0005535_abnormal_body_temperature | 1.18231868 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 1.18221552 |
| 104 | MP0003303_peritoneal_inflammation | 1.18061446 |
| 105 | MP0002998_abnormal_bone_remodeling | 1.16197800 |
| 106 | MP0002184_abnormal_innervation | 1.16129186 |
| 107 | MP0005621_abnormal_cell_physiology | 1.14007477 |
| 108 | MP0002837_dystrophic_cardiac_calcinosis | 1.12957390 |
| 109 | MP0000716_abnormal_immune_system | 1.12442365 |
| 110 | MP0004381_abnormal_hair_follicle | 1.12417521 |
| 111 | MP0002722_abnormal_immune_system | 1.11715157 |
| 112 | MP0001915_intracranial_hemorrhage | 1.11124968 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 1.10585250 |
| 114 | MP0002882_abnormal_neuron_morphology | 1.09512439 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 1.08815572 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 1.07856593 |
| 117 | MP0004883_abnormal_blood_vessel | 1.05681847 |
| 118 | MP0002148_abnormal_hypersensitivity_rea | 1.05496245 |
| 119 | MP0005360_urolithiasis | 1.03806831 |
| 120 | MP0003632_abnormal_nervous_system | 1.03503851 |
| 121 | MP0010307_abnormal_tumor_latency | 1.00519251 |
| 122 | MP0001851_eye_inflammation | 1.00509147 |
| 123 | MP0005085_abnormal_gallbladder_physiolo | 1.00505477 |
| 124 | MP0001177_atelectasis | 1.00482781 |
| 125 | MP0005248_abnormal_Harderian_gland | 1.00372075 |
| 126 | MP0003787_abnormal_imprinting | 0.99691244 |
| 127 | MP0006054_spinal_hemorrhage | 0.98970924 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.98881447 |
| 129 | MP0002229_neurodegeneration | 0.96624054 |
| 130 | MP0002429_abnormal_blood_cell | 0.96535706 |
| 131 | MP0004085_abnormal_heartbeat | 0.96491757 |
| 132 | MP0000689_abnormal_spleen_morphology | 0.95956908 |
| 133 | MP0003172_abnormal_lysosome_physiology | 0.94881365 |
| 134 | MP0002332_abnormal_exercise_endurance | 0.94767505 |
| 135 | MP0005164_abnormal_response_to | 0.94620561 |
| 136 | MP0001545_abnormal_hematopoietic_system | 0.94268342 |
| 137 | MP0005397_hematopoietic_system_phenotyp | 0.94268342 |
| 138 | MP0001502_abnormal_circadian_rhythm | 0.94139747 |
| 139 | MP0003634_abnormal_glial_cell | 0.93117508 |
| 140 | MP0002090_abnormal_vision | 0.93072086 |
| 141 | MP0008961_abnormal_basal_metabolism | 0.92465418 |
| 142 | MP0000767_abnormal_smooth_muscle | 0.92436411 |
| 143 | MP0008872_abnormal_physiological_respon | 0.92280980 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.92198484 |
| 145 | MP0003866_abnormal_defecation | 0.91848671 |
| 146 | MP0002152_abnormal_brain_morphology | 0.91210747 |
| 147 | MP0002069_abnormal_eating/drinking_beha | 0.87143260 |
| 148 | MP0010329_abnormal_lipoprotein_level | 0.86811571 |
| 149 | MP0000751_myopathy | 0.86071485 |
| 150 | MP0002139_abnormal_hepatobiliary_system | 0.84575186 |
| 151 | MP0002796_impaired_skin_barrier | 0.84320820 |
| 152 | MP0001905_abnormal_dopamine_level | 0.83966451 |
| 153 | MP0001348_abnormal_lacrimal_gland | 0.83098778 |
| 154 | MP0005671_abnormal_response_to | 0.81812427 |
| 155 | MP0003300_gastrointestinal_ulcer | 0.80197238 |
| 156 | MP0010678_abnormal_skin_adnexa | 0.79888219 |
| 157 | MP0002086_abnormal_extraembryonic_tissu | 0.76928432 |
| 158 | MP0000490_abnormal_crypts_of | 0.75864706 |
| 159 | MP0001216_abnormal_epidermal_layer | 0.75160338 |
| 160 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73902120 |
| 161 | MP0009764_decreased_sensitivity_to | 0.73273939 |
| 162 | MP0005166_decreased_susceptibility_to | 0.73009082 |
| 163 | MP0001958_emphysema | 0.72966987 |
| 164 | MP0005023_abnormal_wound_healing | 0.72525938 |
| 165 | MP0005384_cellular_phenotype | 0.72219216 |
| 166 | MP0009840_abnormal_foam_cell | 0.72215254 |
| 167 | MP0005645_abnormal_hypothalamus_physiol | 0.72098658 |
| 168 | MP0003646_muscle_fatigue | 0.71761065 |
| 169 | MP0004142_abnormal_muscle_tone | 0.71754826 |
| 170 | MP0006276_abnormal_autonomic_nervous | 0.71639438 |
| 171 | MP0005410_abnormal_fertilization | 0.70715612 |
| 172 | MP0004215_abnormal_myocardial_fiber | 0.68843006 |
| 173 | MP0004036_abnormal_muscle_relaxation | 0.68726042 |
| 174 | MP0005409_darkened_coat_color | 0.67919148 |
| 175 | MP0005365_abnormal_bile_salt | 0.67698908 |
| 176 | MP0003252_abnormal_bile_duct | 0.64756279 |
| 177 | MP0003045_fibrosis | 0.62958927 |
| 178 | MP0002118_abnormal_lipid_homeostasis | 0.62794358 |
| 179 | MP0005448_abnormal_energy_balance | 0.60312858 |
| 180 | MP0004484_altered_response_of | 0.60124589 |
| 181 | MP0005623_abnormal_meninges_morphology | 0.57862688 |
| 182 | MP0010386_abnormal_urinary_bladder | 0.57481189 |
| 183 | MP0002078_abnormal_glucose_homeostasis | 0.56960448 |
| 184 | MP0005551_abnormal_eye_electrophysiolog | 0.56678287 |
| 185 | MP0003191_abnormal_cellular_cholesterol | 0.54188882 |
| 186 | MP0005187_abnormal_penis_morphology | 0.53464957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.28531337 |
| 2 | Focal motor seizures (HP:0011153) | 5.97361156 |
| 3 | Focal seizures (HP:0007359) | 4.87703278 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.02577004 |
| 5 | Visual hallucinations (HP:0002367) | 3.99332791 |
| 6 | Action tremor (HP:0002345) | 3.70568246 |
| 7 | Poor eye contact (HP:0000817) | 3.66324362 |
| 8 | Epileptic encephalopathy (HP:0200134) | 3.64747962 |
| 9 | Impaired social interactions (HP:0000735) | 3.61023697 |
| 10 | Abnormal social behavior (HP:0012433) | 3.61023697 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.51849924 |
| 12 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.47187900 |
| 13 | Atonic seizures (HP:0010819) | 3.33553359 |
| 14 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.31442295 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.31118772 |
| 16 | Cerebral inclusion bodies (HP:0100314) | 3.28781888 |
| 17 | Febrile seizures (HP:0002373) | 3.27840760 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.26364852 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 3.26183986 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.20313165 |
| 21 | Papilledema (HP:0001085) | 3.20306582 |
| 22 | Dysmetric saccades (HP:0000641) | 3.19552675 |
| 23 | Depression (HP:0000716) | 3.17856725 |
| 24 | Hyperventilation (HP:0002883) | 3.14915185 |
| 25 | Absence seizures (HP:0002121) | 3.14867726 |
| 26 | Ankle clonus (HP:0011448) | 3.14434406 |
| 27 | Subacute progressive viral hepatitis (HP:0006572) | 3.13082247 |
| 28 | Urinary urgency (HP:0000012) | 3.07543712 |
| 29 | Dysdiadochokinesis (HP:0002075) | 3.07025064 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 3.03923852 |
| 31 | Postural instability (HP:0002172) | 3.02642905 |
| 32 | Insidious onset (HP:0003587) | 3.00762705 |
| 33 | Termporal pattern (HP:0011008) | 3.00762705 |
| 34 | Dysmetria (HP:0001310) | 2.97243389 |
| 35 | Abnormality of the lower motor neuron (HP:0002366) | 2.94702948 |
| 36 | Dialeptic seizures (HP:0011146) | 2.88888530 |
| 37 | Anxiety (HP:0000739) | 2.87923116 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 2.87138522 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.86736993 |
| 40 | Truncal ataxia (HP:0002078) | 2.84239891 |
| 41 | Intention tremor (HP:0002080) | 2.84175993 |
| 42 | Resting tremor (HP:0002322) | 2.81591973 |
| 43 | Broad-based gait (HP:0002136) | 2.81146724 |
| 44 | Spastic gait (HP:0002064) | 2.78027468 |
| 45 | Torticollis (HP:0000473) | 2.76939900 |
| 46 | Abnormality of the corticospinal tract (HP:0002492) | 2.74510664 |
| 47 | Gingivitis (HP:0000230) | 2.71188512 |
| 48 | Arterial tortuosity (HP:0005116) | 2.70702881 |
| 49 | Orchitis (HP:0100796) | 2.69453371 |
| 50 | Impaired smooth pursuit (HP:0007772) | 2.62721803 |
| 51 | Scanning speech (HP:0002168) | 2.58825264 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58161085 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.56478498 |
| 54 | Peritonitis (HP:0002586) | 2.55087070 |
| 55 | Impaired vibratory sensation (HP:0002495) | 2.52360577 |
| 56 | Myositis (HP:0100614) | 2.45940713 |
| 57 | Lower limb amyotrophy (HP:0007210) | 2.43672842 |
| 58 | Progressive inability to walk (HP:0002505) | 2.43396405 |
| 59 | Excessive salivation (HP:0003781) | 2.43210901 |
| 60 | Drooling (HP:0002307) | 2.43210901 |
| 61 | Status epilepticus (HP:0002133) | 2.42965720 |
| 62 | Syringomyelia (HP:0003396) | 2.40839606 |
| 63 | Spinal cord lesions (HP:0100561) | 2.40839606 |
| 64 | Focal dystonia (HP:0004373) | 2.40067983 |
| 65 | Vascular tortuosity (HP:0004948) | 2.36481727 |
| 66 | Hemiplegia (HP:0002301) | 2.36060308 |
| 67 | Lower limb muscle weakness (HP:0007340) | 2.35833677 |
| 68 | Stereotypic behavior (HP:0000733) | 2.35429701 |
| 69 | Epileptiform EEG discharges (HP:0011182) | 2.35333005 |
| 70 | Cellulitis (HP:0100658) | 2.34983987 |
| 71 | Insomnia (HP:0100785) | 2.32287812 |
| 72 | Abnormality of saccadic eye movements (HP:0000570) | 2.32091828 |
| 73 | Amblyopia (HP:0000646) | 2.31104344 |
| 74 | Hyperacusis (HP:0010780) | 2.30685867 |
| 75 | EEG with generalized epileptiform discharges (HP:0011198) | 2.28849330 |
| 76 | Abnormal eating behavior (HP:0100738) | 2.27942625 |
| 77 | Bradykinesia (HP:0002067) | 2.27233845 |
| 78 | Flat acetabular roof (HP:0003180) | 2.27101316 |
| 79 | Hypsarrhythmia (HP:0002521) | 2.26268177 |
| 80 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.25654238 |
| 81 | Craniofacial dystonia (HP:0012179) | 2.23684991 |
| 82 | Megalencephaly (HP:0001355) | 2.23483724 |
| 83 | Bundle branch block (HP:0011710) | 2.20707875 |
| 84 | Neuronal loss in central nervous system (HP:0002529) | 2.20132610 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.16794202 |
| 86 | Spastic tetraparesis (HP:0001285) | 2.16724645 |
| 87 | Hemiparesis (HP:0001269) | 2.16098596 |
| 88 | Mutism (HP:0002300) | 2.16001410 |
| 89 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.15585132 |
| 90 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.15585132 |
| 91 | Optic neuritis (HP:0100653) | 2.15199726 |
| 92 | Retrobulbar optic neuritis (HP:0100654) | 2.15199726 |
| 93 | Genetic anticipation (HP:0003743) | 2.15153641 |
| 94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.14519915 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 2.14519915 |
| 96 | Diplopia (HP:0000651) | 2.14240339 |
| 97 | Abnormality of binocular vision (HP:0011514) | 2.14240339 |
| 98 | Long palpebral fissure (HP:0000637) | 2.13892512 |
| 99 | Asymmetry of the thorax (HP:0001555) | 2.13791962 |
| 100 | Annular pancreas (HP:0001734) | 2.09290736 |
| 101 | T lymphocytopenia (HP:0005403) | 2.08738878 |
| 102 | Clonus (HP:0002169) | 2.07050780 |
| 103 | Blue irides (HP:0000635) | 2.06723783 |
| 104 | Viral hepatitis (HP:0006562) | 2.05846565 |
| 105 | Abnormality of the periventricular white matter (HP:0002518) | 2.04760864 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 2.04379695 |
| 107 | Broad face (HP:0000283) | 2.00897128 |
| 108 | Slow saccadic eye movements (HP:0000514) | 1.99044525 |
| 109 | Amyotrophic lateral sclerosis (HP:0007354) | 1.98361852 |
| 110 | Vertebral compression fractures (HP:0002953) | 1.98336963 |
| 111 | Micronodular cirrhosis (HP:0001413) | 1.96637342 |
| 112 | Myocardial infarction (HP:0001658) | 1.96542291 |
| 113 | Heterotopia (HP:0002282) | 1.96069762 |
| 114 | Upper motor neuron abnormality (HP:0002127) | 1.95566504 |
| 115 | Recurrent skin infections (HP:0001581) | 1.94560734 |
| 116 | Gastrointestinal infarctions (HP:0005244) | 1.94171203 |
| 117 | Pointed chin (HP:0000307) | 1.93356828 |
| 118 | Distal lower limb amyotrophy (HP:0008944) | 1.91665589 |
| 119 | Recurrent fungal infections (HP:0002841) | 1.91123361 |
| 120 | Spondylolisthesis (HP:0003302) | 1.90230925 |
| 121 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.89524406 |
| 122 | Pheochromocytoma (HP:0002666) | 1.89360608 |
| 123 | Global brain atrophy (HP:0002283) | 1.88015328 |
| 124 | Generalized myoclonic seizures (HP:0002123) | 1.87645976 |
| 125 | Difficulty running (HP:0009046) | 1.85406252 |
| 126 | Abnormality of the peritoneum (HP:0002585) | 1.85354639 |
| 127 | Mediastinal lymphadenopathy (HP:0100721) | 1.85236695 |
| 128 | Absent frontal sinuses (HP:0002688) | 1.84402629 |
| 129 | Gait ataxia (HP:0002066) | 1.83976201 |
| 130 | Ankyloglossia (HP:0010296) | 1.82387155 |
| 131 | Papillary thyroid carcinoma (HP:0002895) | 1.82140031 |
| 132 | Inappropriate behavior (HP:0000719) | 1.81745530 |
| 133 | Abnormality of T cell number (HP:0011839) | 1.81586647 |
| 134 | Dilatation of the ascending aorta (HP:0005111) | 1.81244333 |
| 135 | Abnormal gallbladder physiology (HP:0012438) | 1.81173034 |
| 136 | Cholecystitis (HP:0001082) | 1.81173034 |
| 137 | Deep philtrum (HP:0002002) | 1.80241076 |
| 138 | Osteomyelitis (HP:0002754) | 1.80050485 |
| 139 | Psychosis (HP:0000709) | 1.79873239 |
| 140 | Rigidity (HP:0002063) | 1.79358556 |
| 141 | Abnormality of oral frenula (HP:0000190) | 1.79269940 |
| 142 | Recurrent viral infections (HP:0004429) | 1.78600813 |
| 143 | Loss of speech (HP:0002371) | 1.77760529 |
| 144 | Macroorchidism (HP:0000053) | 1.77610536 |
| 145 | Thick nail (HP:0001805) | 1.77456378 |
| 146 | Urticaria (HP:0001025) | 1.77099231 |
| 147 | Decreased motor nerve conduction velocity (HP:0003431) | 1.75842701 |
| 148 | Thin bony cortex (HP:0002753) | 1.75738411 |
| 149 | Deep venous thrombosis (HP:0002625) | 1.75625946 |
| 150 | Sensorimotor neuropathy (HP:0007141) | 1.74813764 |
| 151 | Abnormality of glycolipid metabolism (HP:0010969) | 1.73731933 |
| 152 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.73731933 |
| 153 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.73731933 |
| 154 | Absent speech (HP:0001344) | 1.73149968 |
| 155 | Stomatitis (HP:0010280) | 1.72573777 |
| 156 | Tetraplegia (HP:0002445) | 1.72382590 |
| 157 | Cerebral aneurysm (HP:0004944) | 1.72038914 |
| 158 | Onion bulb formation (HP:0003383) | 1.71910386 |
| 159 | Short nail (HP:0001799) | 1.71120436 |
| 160 | Rapidly progressive (HP:0003678) | 1.70724035 |
| 161 | Vertebral arch anomaly (HP:0008438) | 1.69718730 |
| 162 | Periodontitis (HP:0000704) | 1.68772703 |
| 163 | Apathy (HP:0000741) | 1.68760123 |
| 164 | Recurrent cutaneous fungal infections (HP:0011370) | 1.67735180 |
| 165 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.67735180 |
| 166 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.67712931 |
| 167 | Abnormality of vision evoked potentials (HP:0000649) | 1.67000627 |
| 168 | Aneurysm (HP:0002617) | 1.66813240 |
| 169 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.66622715 |
| 170 | Cholelithiasis (HP:0001081) | 1.66559103 |
| 171 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66424225 |
| 172 | Chest pain (HP:0100749) | 1.66252049 |
| 173 | Disproportionate tall stature (HP:0001519) | 1.63366841 |
| 174 | Coarse hair (HP:0002208) | 1.63299969 |
| 175 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.61802058 |
| 176 | Mucopolysacchariduria (HP:0008155) | 1.61802058 |
| 177 | Orthostatic hypotension (HP:0001278) | 1.61662101 |
| 178 | Increased IgE level (HP:0003212) | 1.61388424 |
| 179 | Uterine leiomyosarcoma (HP:0002891) | 1.60942089 |
| 180 | Leiomyosarcoma (HP:0100243) | 1.60942089 |
| 181 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.60567114 |
| 182 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.60264529 |
| 183 | Gingival bleeding (HP:0000225) | 1.59568200 |
| 184 | Fatigue (HP:0012378) | 1.59311729 |
| 185 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.59046695 |
| 186 | Episodic fever (HP:0001954) | 1.58496270 |
| 187 | Bladder carcinoma (HP:0002862) | 1.58303798 |
| 188 | Bladder neoplasm (HP:0009725) | 1.58303798 |
| 189 | Dysostosis multiplex (HP:0000943) | 1.57505814 |
| 190 | Abnormality of the fingertips (HP:0001211) | 1.55951732 |
| 191 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.55949363 |
| 192 | Arterial thrombosis (HP:0004420) | 1.54825009 |
| 193 | Bone pain (HP:0002653) | 1.53614296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.08598399 |
| 2 | NTRK3 | 3.49239143 |
| 3 | MAP3K9 | 3.36614171 |
| 4 | DAPK2 | 2.89985144 |
| 5 | CDK12 | 2.87350556 |
| 6 | MARK1 | 2.65201372 |
| 7 | EPHB1 | 2.63158495 |
| 8 | MAP3K4 | 2.62841555 |
| 9 | IRAK3 | 2.61206242 |
| 10 | RIPK4 | 2.55510329 |
| 11 | MAP2K3 | 2.50083218 |
| 12 | KSR2 | 2.44262880 |
| 13 | ERN1 | 2.37665719 |
| 14 | SMG1 | 2.29807818 |
| 15 | PRKD3 | 2.24054308 |
| 16 | PAK6 | 2.07404906 |
| 17 | CAMKK1 | 2.01628002 |
| 18 | MINK1 | 1.98676711 |
| 19 | PRPF4B | 1.97794048 |
| 20 | MAP3K13 | 1.93296646 |
| 21 | MAP3K14 | 1.87048408 |
| 22 | NTRK1 | 1.85931920 |
| 23 | IRAK4 | 1.84740238 |
| 24 | NTRK2 | 1.83785737 |
| 25 | TYK2 | 1.67289601 |
| 26 | CSK | 1.62928359 |
| 27 | MAP2K7 | 1.60002273 |
| 28 | KSR1 | 1.59150487 |
| 29 | FGFR4 | 1.58559223 |
| 30 | MAP4K1 | 1.58103120 |
| 31 | MAP3K3 | 1.55349335 |
| 32 | MAP2K4 | 1.50493099 |
| 33 | CDK5 | 1.49387272 |
| 34 | YES1 | 1.48606689 |
| 35 | BLK | 1.47640784 |
| 36 | SIK2 | 1.44043254 |
| 37 | SIK3 | 1.43268328 |
| 38 | ZAP70 | 1.41331618 |
| 39 | DAPK1 | 1.40311625 |
| 40 | SGK3 | 1.38749193 |
| 41 | TAOK3 | 1.37904882 |
| 42 | SIK1 | 1.35385817 |
| 43 | FES | 1.35266282 |
| 44 | PRKCH | 1.33394885 |
| 45 | JAK3 | 1.30207674 |
| 46 | SGK223 | 1.29620734 |
| 47 | SGK494 | 1.29620734 |
| 48 | MAP3K10 | 1.27799787 |
| 49 | SGK2 | 1.26341522 |
| 50 | PTK2B | 1.22831541 |
| 51 | PDGFRA | 1.21462070 |
| 52 | TTN | 1.17221457 |
| 53 | TRIB3 | 1.15357038 |
| 54 | TYRO3 | 1.14898321 |
| 55 | MAP3K2 | 1.10362326 |
| 56 | RET | 1.09450274 |
| 57 | PDK1 | 1.07472360 |
| 58 | ARAF | 1.06727998 |
| 59 | BRD4 | 1.05629199 |
| 60 | STK38 | 1.00888430 |
| 61 | IRAK2 | 1.00426644 |
| 62 | PDPK1 | 0.98850855 |
| 63 | TAOK2 | 0.98202740 |
| 64 | FGFR2 | 0.98175619 |
| 65 | STK11 | 0.97335775 |
| 66 | TGFBR2 | 0.94735616 |
| 67 | PTK6 | 0.94014623 |
| 68 | STK10 | 0.93215282 |
| 69 | RAF1 | 0.93077779 |
| 70 | RIPK1 | 0.92443074 |
| 71 | CDK6 | 0.90442744 |
| 72 | IRAK1 | 0.90414305 |
| 73 | CAMK1D | 0.87585323 |
| 74 | SGK1 | 0.87051684 |
| 75 | PLK2 | 0.86822344 |
| 76 | HCK | 0.86119281 |
| 77 | CDC42BPA | 0.84433848 |
| 78 | MELK | 0.83748348 |
| 79 | PHKG1 | 0.83270380 |
| 80 | PHKG2 | 0.83270380 |
| 81 | PAK4 | 0.83039153 |
| 82 | PRKCG | 0.82712056 |
| 83 | PDGFRB | 0.82503778 |
| 84 | TAOK1 | 0.82016105 |
| 85 | PRKD2 | 0.82007957 |
| 86 | CAMKK2 | 0.81946237 |
| 87 | LMTK2 | 0.80675888 |
| 88 | MAP3K6 | 0.79637131 |
| 89 | LRRK2 | 0.78031639 |
| 90 | JAK1 | 0.77751147 |
| 91 | WNK1 | 0.77343578 |
| 92 | MAPK13 | 0.77152662 |
| 93 | NEK6 | 0.75144921 |
| 94 | MAP3K7 | 0.74727946 |
| 95 | PTK2 | 0.74208269 |
| 96 | CASK | 0.72823485 |
| 97 | MTOR | 0.72580164 |
| 98 | IKBKE | 0.72503174 |
| 99 | ALK | 0.72314801 |
| 100 | PAK3 | 0.71838239 |
| 101 | MST1R | 0.71666006 |
| 102 | MAP3K8 | 0.71644382 |
| 103 | CAMK2A | 0.70916071 |
| 104 | CAMK1G | 0.70188683 |
| 105 | MARK2 | 0.69291168 |
| 106 | BTK | 0.67920618 |
| 107 | TESK2 | 0.67314154 |
| 108 | CDK15 | 0.66300903 |
| 109 | PKN1 | 0.65393695 |
| 110 | PKN2 | 0.65363591 |
| 111 | CDK18 | 0.65208097 |
| 112 | UHMK1 | 0.65147992 |
| 113 | EPHA2 | 0.64246395 |
| 114 | PRKCZ | 0.63636480 |
| 115 | FYN | 0.63162526 |
| 116 | MATK | 0.62953227 |
| 117 | EPHA3 | 0.62804792 |
| 118 | PDK4 | 0.61815427 |
| 119 | PDK3 | 0.61815427 |
| 120 | CAMK2B | 0.61525614 |
| 121 | HIPK2 | 0.61056086 |
| 122 | NEK9 | 0.59823559 |
| 123 | PINK1 | 0.59377836 |
| 124 | TBK1 | 0.59266126 |
| 125 | PRKCQ | 0.58914011 |
| 126 | CDK14 | 0.58594200 |
| 127 | BMPR2 | 0.57921470 |
| 128 | GRK5 | 0.57306729 |
| 129 | CSNK1G2 | 0.55346921 |
| 130 | RPS6KA3 | 0.54874373 |
| 131 | ICK | 0.53096050 |
| 132 | MAP2K1 | 0.52450810 |
| 133 | CDK11A | 0.52248188 |
| 134 | LATS2 | 0.51898279 |
| 135 | CDK4 | 0.51636624 |
| 136 | EIF2AK1 | 0.51077599 |
| 137 | MAP3K12 | 0.50281021 |
| 138 | DMPK | 0.50222841 |
| 139 | GRK6 | 0.49289106 |
| 140 | DYRK1B | 0.49205198 |
| 141 | CSF1R | 0.48967999 |
| 142 | CAMK1 | 0.47995889 |
| 143 | MAP3K1 | 0.47487889 |
| 144 | RPS6KA2 | 0.46716550 |
| 145 | MAP3K11 | 0.45119510 |
| 146 | FGR | 0.44994139 |
| 147 | EEF2K | 0.44891432 |
| 148 | BMX | 0.44888664 |
| 149 | MOS | 0.44879347 |
| 150 | LCK | 0.43328361 |
| 151 | MAP3K5 | 0.43063189 |
| 152 | JAK2 | 0.42562269 |
| 153 | PDK2 | 0.41776115 |
| 154 | SYK | 0.41640231 |
| 155 | FGFR3 | 0.41062868 |
| 156 | MAPK10 | 0.39944679 |
| 157 | TESK1 | 0.39363787 |
| 158 | MAPK12 | 0.39339926 |
| 159 | PRKCB | 0.39319971 |
| 160 | TNK2 | 0.39048478 |
| 161 | DAPK3 | 0.38583300 |
| 162 | CLK1 | 0.36997569 |
| 163 | FRK | 0.36715102 |
| 164 | CAMK4 | 0.36232101 |
| 165 | SCYL2 | 0.35721617 |
| 166 | PRKAA1 | 0.35103858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 2.80591271 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.43472958 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.43462296 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.33478343 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.28953614 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.27867986 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.24682829 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.24538631 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.23682074 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.18055165 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.15633966 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.03864898 |
| 13 | Pancreatic cancer_Homo sapiens_hsa05212 | 2.02491282 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.02198409 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.92832749 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90544444 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.90145799 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.79980698 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76246763 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.71383824 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.65669455 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59815430 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.59340545 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58546515 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.56816400 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56720161 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.55712316 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.53095168 |
| 29 | Thyroid cancer_Homo sapiens_hsa05216 | 1.52858187 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.51927873 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49106139 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.45800648 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44171011 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42975200 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40920644 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.40450712 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40412716 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36971631 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36122017 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.32669999 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30005479 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28468440 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.27019900 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27001886 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26684990 |
| 46 | Colorectal cancer_Homo sapiens_hsa05210 | 1.25564587 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 1.24680315 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24230442 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.22992026 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.22248928 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.22020246 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21698503 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21050094 |
| 54 | Prostate cancer_Homo sapiens_hsa05215 | 1.19428419 |
| 55 | Taste transduction_Homo sapiens_hsa04742 | 1.18980073 |
| 56 | Gap junction_Homo sapiens_hsa04540 | 1.18676304 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16567904 |
| 58 | Malaria_Homo sapiens_hsa05144 | 1.16396454 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 1.15596763 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15508166 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.15124857 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15005900 |
| 63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.14739421 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 1.13403184 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 1.10321683 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10117514 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09748675 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08411531 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 1.07838897 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06103833 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05504827 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04072571 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04053285 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04034606 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 1.03168803 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03163578 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.02729917 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00895931 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.00882362 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 1.00573694 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98102272 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98046802 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.95615818 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92868482 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92508276 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90119187 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.89636965 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89177046 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.88865398 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87215765 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87084245 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86490294 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85428930 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.84707751 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.84012204 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83816256 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83644723 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77853680 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76199223 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.76190082 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.76030106 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.75333110 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74859141 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73414051 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73210266 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72395307 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70475199 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68418249 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67779705 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67611267 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67244475 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66389529 |
| 113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65426118 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64376846 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.62729962 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.62687785 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62656980 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61062780 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60563346 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59390259 |
| 121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58887671 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58822654 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58545920 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58335417 |
| 125 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.57739221 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57657407 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57384609 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56669348 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56588646 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56560330 |
| 131 | Pertussis_Homo sapiens_hsa05133 | 0.56401340 |
| 132 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55701436 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54410376 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54121252 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54105488 |
| 136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53592203 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.53143033 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52658533 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52067063 |
| 140 | Melanoma_Homo sapiens_hsa05218 | 0.51446224 |
| 141 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51294358 |
| 142 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50641249 |
| 143 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50475207 |
| 144 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50287663 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50220888 |
| 146 | Insulin resistance_Homo sapiens_hsa04931 | 0.46538545 |
| 147 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46097850 |
| 148 | Alcoholism_Homo sapiens_hsa05034 | 0.45884085 |
| 149 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44946390 |
| 150 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44774927 |
| 151 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44704459 |
| 152 | Prion diseases_Homo sapiens_hsa05020 | 0.43819275 |
| 153 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42319883 |
| 154 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42043707 |
| 155 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41492030 |
| 156 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41032240 |
| 157 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39745611 |
| 158 | ABC transporters_Homo sapiens_hsa02010 | 0.39395803 |
| 159 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37950229 |
| 160 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36739407 |
| 161 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36290464 |

